xl-082

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namexl-082
Drug Alias NamePAS-IFN super agonist (XL-Protein)PAS-YNSalpha8
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterferons stimulants
TargetsInterferons
Therapy Area/IndicationsMultiple SclerosisVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXL-protein GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A